Retina Specialty Institute (01-019) — Pensacola, Florida

Retina Specialty Institute (01-019) is a clinical research site located in Pensacola, Florida, United States 32503.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Retina Specialty Institute (01-019) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Geographic Atrophy.

Sponsors: Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Specialty Institute (01-019)?

Retina Specialty Institute (01-019) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Specialty Institute (01-019) conducted?

Retina Specialty Institute (01-019) has 1 clinical trials on record, with 1 currently active. Their work covers Geographic Atrophy.

Is Retina Specialty Institute (01-019) accredited by Crixeo Health?

Retina Specialty Institute (01-019) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Specialty Institute (01-019)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.